II. Epidemiology
- Infertility Prevalence: 15% of couples
- Male factors contribute to two thirds of Infertility
- One third of Infertility cases due to male only
- One third of Infertility cases due to both partners
III. Causes
- Idiopathic (40-50%)
-
Primary Hypogonadism (Testicular Failure): 30-40%
- Varicocele (40%)
- Medication of drug use (See Gonadotoxin)
- Exposures
- Excessive Heat Exposure (hot tubs, saunas)
- Toxic chemicals
- Pesticides
- Testicular surgeries or injury
- Cryptorchidism
- Chromosomal abnormality
- Y Deletions
- Small Testes, low Sperm Count
- Klinefelter Syndrome (XXY)
- Learning Disorders, Tall Stature, Gynecomastia
- Small Testes, Low Sperm Count
- Low Testosterone, increased FSH
- Cystic Fibrosis is associated with vas deferens absence
- Related genes: CFTR gene, 5T Allele
- Y Deletions
- Genital radiation or Chemotherapy
- Orchitis
- Post-pubertal mumps
- Sexually Transmitted Disease
- Obstructive azoospermia or altered transport (10-20%)
- Erectile Dysfunction
- Retrograde ejaculation or other dysfunction
- Hypospadias
- Vas deferens absence (e.g. Cystic Fibrosis)
- Epididymal absence
-
Secondary Hypogonadism (Hypothalamic-Pituitary Axis):2%
- Hypogonadotropic Hypogonadism
- Androgen Excess (e.g. Anabolic Steroids)
- Estrogen excess (e.g. tumor)
- Pituitary Adenoma
- Hemochromatosis
- Kallman Syndrome
- Infiltrative Disorder
IV. History
- See Infertility for coital factor history
- Childhood illnesses (e.g. mumps)
- Comorbid condition
- Prior surgeries
- Cryptorchidism
- Testicular Torsion
- Genitourinary ot retroperitoneal surgery
- Social history
- Gonadotoxin use (Medications that Impair Male Fertility)
- Toxin exposures (e.g. Heavy Metals, Pesticides)
- Substances (Tobacco, Alcohol, ilicit drug use)
-
Sexual History
- Sexually Transmitted Infection history
- Erectile Dysfunction
- Libido
-
Review of Systems
- Anosmia (Kallmann's Syndrome)
-
Chronic Sinusitis and Bronchiectasis
- Young's Syndrome
- Kartagener's Syndrome (also with Situs inversus)
- Visual Field Defect, Galactorrhea (Pituitary Lesion)
V. Exam
-
Body Mass Index
- Obesity impacts semen quality and Erectile Dysfunction
- Signs of Endocrinopathy (Hypogonadotropic Hypogonadism)
- Thyromegaly
- Dermatologic changes in hair or fat
- Genital exam
- Hypospadias
- Assess testicular size
- Normal >20 cm or >4 cm in diameter
- Assess vas deferens and epididymis
- Vas deferens may be absent on exam in Cystic Fibrosis
- Varicocele
-
Rectal Exam
- Assess Prostate Gland for Nodules or swelling
VI. Evaluation
- Step 1: Semen Analysis
- Obtain 2 samples at 2-3 months apart
- Best samples are after 2 to 5 days of abstinence
- Three month interval between tests reflects a >2 month sperm generation time
- Normal Semen Analysis
- Evaluate for Female Infertility
- Discontinue Gonadotoxins
- Discontinue lubricant use with intercourse
- Reevaluate timing of intercourse during Ovulation
- Abnormal Semen Analysis
- Varicocele present
- Consider referral to Urology for repair
- Inadequate data to suggest corrective surgery improves conception rates
- No Varicocele present
- Go to Step 2a Below
- Varicocele present
- Leukospermia (>1 million WBCs per ml)
- Diagnosis requires additional staining of WBCs
- May be consistent with Prostatitis
- Treat with Doxycycline 100 mg PO bid for 2 weeks
- Repeat Semen Analysis after treatment
- Azoospermia (No sperm present): 10-15% of cases
- Refer to Male Infertility clinic
- Further evaluation will distinguish causes
- Vas deferens abnormality (absence, Vasectomy)
- Hypogonadotropic Hypogonadism
- Testicular abnormality
- Obtain 2 samples at 2-3 months apart
- Step 2a: Is semen volume <1.5 ml?
- No: Semen volume normal: Go to Step 3
- Yes: Semen volume <1.5 ml: Go to Step 2b
- Step 2b: Obtain post-ejaculatory urine analysis
- Positive: Retrograde Ejaculation
- Consider Pseudophedrine 60 mg orally three times daily
- Negative: Possible ejaculatory duct obstruction
- Follicle Stimulating Hormone (FSH)
- Refer to Urology (and Transrectal Ultrasound)
- Positive: Retrograde Ejaculation
- Step 3: Evaluate sperm concentration
- Sperm >10-15 million/ml
- Refer to Male Infertility clinic
- Sperm <10-15 million/ml (Oligospermia)
- Suggests Hypogonadism
- Primary Hypogonadism presents with increased FSH and decreased Serum Testosterone
- Secondary Hypogonadism presents with decreased FSH and decreased Serum Testosterone
- Refer to Male Infertility clinic
- Follicle Stimulating Hormone (FSH)
- Serum Testosterone
- Serum Prolactin
- Genetic Counseling for sperm <5 million/ml
- Suggests Hypogonadism
- Sperm >10-15 million/ml
VII. Management: Non-specific options
- In Vitro Fertilization (with or without intracytoplasmic sperm injection)
- Standard approach to Male Infertility without reversible cause
- Hormonal agents
- Antiestrogens
- Gonadotropins
- Attia (2013) Cochrane Database Syst Rev (8): CD005071 [PubMed]
- Antioxidants
- Zinc supplementation
- Vitamin E Supplementation
- L-Carnitine supplementation
- Showell (2011) Cochrane Database Syst Rev (1): CD007411 [PubMed]
VIII. References
- (2004) Fertil Steril 82(Suppl 1):S102-6 [PubMed]
- De Krester (1997) Lancet 349:787-90 [PubMed]
- Kolettis (2003) Am Fam Physician 67(10):2165-72 [PubMed]
- Kolettis (2001) J Urol 166:178-80 [PubMed]
- Lindsay (2014) Am Fam Physician 91(5): 308-14 [PubMed]
- Sharlip (2002) Fertil Steril 77:873-82 [PubMed]
- Sigman (1997) Urology 50:659-64 [PubMed]